Ebrahimi Rasoul, Bordbar Sanaz, Azad Ghazal, Davoody Samin, Mahmoudi MahSima, Esmaeilpour Khadijeh
School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Neurol Sci. 2025 Aug 19. doi: 10.1007/s10072-025-08403-4.
Microglia, the brain's resident immune cells, are increasingly recognized as central players in the complex landscape of Alzheimer's disease (AD). Traditionally associated with neuroinflammation, their roles extend far beyond, touching nearly every aspect of disease progression-from amyloid β (Aβ) and tau pathology to synaptic integrity and cognitive function. While early studies focused on their inflammatory responses, recent findings highlight a more nuanced picture: microglia can both protect and harm, depending on their state and the disease context. In this review, we examine the diverse functions of microglia at the crossroads of Aβ and tau pathology, emphasizing how dysfunction in their regulatory and clearance mechanisms can exacerbate neurodegeneration. We also explore how these insights are shaping therapeutic strategies aimed at modulating microglial activity to preserve brain health. By broadening the focus beyond inflammation alone, this work presents a more integrated view of microglial involvement in AD pathogenesis.
小胶质细胞是大脑中的常驻免疫细胞,在阿尔茨海默病(AD)复杂的病理过程中,它们越来越被视为核心参与者。传统上认为小胶质细胞与神经炎症有关,但其作用远不止于此,几乎涉及疾病进展的方方面面——从淀粉样β蛋白(Aβ)和tau蛋白病理到突触完整性和认知功能。早期研究聚焦于它们的炎症反应,而最近的研究结果则揭示了一幅更为细致入微的图景:小胶质细胞既能起到保护作用,也能造成损害,这取决于它们的状态和疾病背景。在这篇综述中,我们研究了小胶质细胞在Aβ和tau蛋白病理交叉点上的多种功能,强调其调节和清除机制的功能障碍如何加剧神经退行性变。我们还探讨了这些见解如何塑造旨在调节小胶质细胞活性以维护大脑健康的治疗策略。通过将关注点从单纯的炎症扩展,这项工作呈现了小胶质细胞参与AD发病机制的更全面观点。